Home About Us Products Innovation Partners Leadership Contact

Next-Generation Healthcare

Innovation at the Forefront

Pioneering technologies that redefine surgical precision, diagnostics, and cancer detection — from image-guided navigation to pocket-sized radiography and AI-powered breath analysis.

✦ EPED Inc. Taiwan

RETINA — Surgical Navigation System

The RETINA combines intelligent medical technologies to integrate digital medical imaging for better surgical accuracy — compatible with a vast range of OR instruments, reducing tissue injuries and improving patient outcomes.

RETINA

ENT · Neurosurgery · Craniofacial

Advanced image-guided navigation for complex ENT, brain, and craniofacial procedures — integrating CT+MRI fusion with real-time surgical path guidance and optical tracking.

CT + MRI Fusion: Visualise soft and hard tissue simultaneously on-screen for better surgical reference.

Guidance Mode: Real-time feedback of intra-operative position, depth, and angle for accurate navigation.

Segmentation: Colour-mark surgical targets and create precise surgery paths and object-targeting procedures.

Nerve Delimitation: Trace nerves and blood vessels to avoid unnecessary intraoperative damage.

Plate Positioning (Craniofacial): 3D bone modelling and mirroring for reconstructive and maxillofacial surgery.

Surgical Path Planning: Create and follow precise surgical paths accurately throughout the procedure.

Surgical Specialties

ENT

Sinus, skull base, and otological surgery with real-time navigational accuracy.

Neurosurgery

Brain navigation with CT+MRI fusion, segmentation, and nerve delimitation.

Craniofacial

3D bone modelling, plate positioning, and mirroring for reconstructive procedures.

Core Technology

Optical Tracking
No EM components
CT + MRI Fusion
Dual modality imaging
Sterile Instruments
Stainless steel sets
Minimally Invasive
Reduced tissue injury
Request a Demo EPED Website

RETINA-Nova

Neurosurgery · ENT · Craniofacial

Advanced image-guided navigation for complex brain, ENT, and craniofacial procedures. Integrates CT+MRI fusion with real-time surgical path guidance.

CT + MRI Fusion: Visualise soft and hard tissue simultaneously on-screen.

Segmentation: Colour-mark surgical targets and create precise surgery paths.

Nerve Delimitation: Trace nerves and blood vessels to avoid intraoperative damage.

Guidance Mode: Real-time feedback of intra-operative position, depth, and angle.

Plate Positioning (Craniofacial): 3D bone modelling and mirroring for reconstructive surgery.

✦ TRUE INNOVATION

Handheld Digital Radiography

The world's most advanced pocket-sized DR system — bringing diagnostic-grade imaging to every point of care, without compromise.

Why Handheld DR is a Game-Changer

Point-of-Care Deployment

Take X-rays at the patient's bedside, in the ICU, emergency room, operating theatre, or even in rural health camps — no room preparation needed.

Fully Wireless Operation

Wi-Fi and Bluetooth connectivity means images are transmitted instantly to PACS, tablets, or smartphones — no cables, no delays.

Battery-Powered Freedom

Long-lasting rechargeable battery — operate a full clinical day without needing a power outlet. Perfect for power-interrupted environments.

Diagnostic-Grade Image Quality

High-resolution digital radiography images comparable to conventional fixed DR systems — no compromise on diagnostic accuracy.

Technical Highlights

3.4 kg
Device Weight
<2 min
Setup Time
Wi-Fi
+ Bluetooth
DICOM
Fully Compliant

Use Cases

Bedside / ICU

Immediate imaging for critical patients without transport risk.

Emergency

Rapid trauma imaging in emergency and casualty settings.

Rural Outreach

Diagnostic imaging for underserved communities and health camps.

Coming Soon · In Clinical Validation

OBA-L™ — Onco Breath Analyser (Lung)

Non-invasive early screening of lung cancer through breath analysis under 90 seconds using patented VolTrac™ VOC sensor technology (up to parts-per-trillion detection). Indian Patent Granted 2024. Clinical validation at Malabar Cancer Centre. CDSCO approval in progress.

Invent

OBA-L™

by Invent | Indian Patent Granted 2024

Detection Time
<90 seconds
Method
Non-invasive breath analysis
Technology
VolTrac™ VOC sensor
Sensitivity
Parts-per-trillion (PPT) detection
AI Analysis
Pattern recognition for risk stratification
Patent Status
Indian Patent 2024 + International Filed
Clinical Validation
Malabar Cancer Centre (MCC), Thalassery
Regulatory Path
Working toward CDSCO approval

Why OBA-L™ Matters

Lung cancer is the leading cause of cancer mortality globally. The OBA-L™ Onco Breath Analyser offers a revolutionary non-invasive screening pathway — no needles, no radiation, no discomfort. Simply breathe into the device and receive a risk assessment in under 90 seconds.

Powered by Invent's proprietary VolTrac™ volatile organic compound (VOC) sensor technology, OBA-L™ detects cancer biomarkers at sub-parts-per-billion concentrations — enabling early detection when treatment outcomes are most favorable.

Target Screening Population

Smokers
Occupational Exposure
Family History
Chronic Respiratory
Mass Screening Programs
High-Risk Populations

Clinical Validation Status

Currently undergoing clinical validation at Malabar Cancer Centre (MCC), Thalassery — one of India's premier cancer research and treatment institutions. Working toward CDSCO regulatory approval for commercial deployment in India.